Merck Canada Inc.
USPTO PatentsView assignee record - 19 granted patents across 7 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).
The verdict
According to USPTO PatentsView, Merck ranks #15,456 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 7 technology areas.
- #15,456
- of 49,997 US assignees by volume
- 31st percentile
- by Innovation Score (29.6/100)
- 16.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R15456 · Foreign Corporation #15,456 · 19 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 19 grants
- MID-PACK #15,456/49,997
- PHOTO-FINISH Maschinenfabrik…
- CPC-NARROW C07D · 7 areas
- INNOV-THIN 29.6/100
- CLAIMS-RICH 16.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Maschinenfabrik Gustav Eirich GmbH & Co. KG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Merck’s 29.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Merck
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Merck Canada · this assignee 30
Merck Canada · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Merck's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Merck?
Each dot is one of Merck’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Merck’s own 16.6 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Merck's grants concentrate
Merck Canada Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (7 grants) versus a trough of 2 in 2018. By volume, Merck sits between Maschinenfabrik Gustav Eirich GmbH & Co. KG and Mitsubishi Electric US, Inc..
Who files at Merck's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Maschinenfabrik G…
Maschinenfabrik Gustav Eirich GmbH & Co. KG
19 patents
- Massively Parallel
Massively Parallel Technologies, Inc.
19 patents
- Mast Industries (…
Mast Industries (Far East) Limited
19 patents
- Mcelroy Manufactu…
McElroy Manufacturing, Inc.
19 patents
- Meridian Internat…
Meridian International Co., Ltd
19 patents
- Metabolic
Metabolic Technologies, LLC
19 patents
- Microlin
Microlin, LLC
19 patents
- Mitsubishi Electr…
Mitsubishi Electric US, Inc.
19 patents
- Merck Canada ◀
Merck Canada Inc.
19 patents
What this shows Merck holds 19 patents at rank #15,464, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Merck
By rank, the assignees closest to #15,464 in granted patent volume.
- Maschinenfabrik Gustav Eirich GmbH & Co. KG #15,460 · 19 patents
- Massively Parallel Technologies, Inc. #15,461 · 19 patents
- Mast Industries (Far East) Limited #15,462 · 19 patents
- McElroy Manufacturing, Inc. #15,463 · 19 patents
- Meridian International Co., Ltd #15,465 · 19 patents
- Metabolic Technologies, LLC #15,466 · 19 patents
- Microlin, LLC #15,467 · 19 patents
- Mitsubishi Electric US, Inc. #15,468 · 19 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Merck's primary technology class.
Merck's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 31st percentile higher than 31% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 36.8% |
| 2016 | 5 | 26.3% |
| 2017 | 5 | 26.3% |
| 2018 | 2 | 10.5% |
Which technologies does Merck Canada Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Merck Canada Inc.'s patent record in context - here's where to go next.
- Merck Canada Inc.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
- Ranked #15,456 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Merck Canada Inc. against Maschinenfabrik Gustav Eirich GmbH & Co. KG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.